ESTRADIOL

ESTRADIOL was reported 86535 times

ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OESTRADIOL DECREASED 167 0.5186
1 BLOOD OESTROGEN DECREASED 247 0.3514
2 ADHESIVE TAPE USE 98 0.2552
3 DERMAL ABSORPTION IMPAIRED 69 0.2464
4 MENOPAUSAL SYMPTOMS 490 0.2103
5 BLOOD OESTROGEN INCREASED 102 0.1732
6 PRODUCT ADHESION ISSUE 6148 0.1719
7 VULVOVAGINAL DISCOMFORT 759 0.1716
8 OESTROGEN RECEPTOR ASSAY POSITIVE 190 0.1675
9 PROGESTERONE RECEPTOR ASSAY POSITIVE 156 0.1668
10 VULVOVAGINAL INJURY 70 0.1228
11 VULVOVAGINAL DRYNESS 361 0.1115
12 VULVOVAGINAL ERYTHEMA 92 0.1100
13 PRODUCT DESIGN ISSUE 78 0.1091
14 ATROPHIC VULVOVAGINITIS 79 0.1081
15 SCHIZOAFFECTIVE DISORDER 188 0.1053
16 PRODUCT INEFFECTIVE 80 0.1018
17 APPLICATION SITE HYPERSENSITIVITY 123 0.1012
18 SOFT TISSUE DISORDER 112 0.1010
19 VULVOVAGINAL BURNING SENSATION 594 0.0972
20 APPLICATION SITE RASH 1333 0.0968
21 VULVOVAGINAL PAIN 454 0.0942
22 APPLICATION SITE SCAR 116 0.0927
23 DEVICE ADHESION ISSUE 1410 0.0918
24 BREAST CANCER FEMALE 2437 0.0911
25 POSTMENOPAUSAL HAEMORRHAGE 234 0.0897
26 APPLICATION SITE URTICARIA 195 0.0868
27 VAGINAL ODOUR 104 0.0827
28 INCORRECT DOSE ADMINISTERED BY PRODUCT 127 0.0793
29 FIBROCYSTIC BREAST DISEASE 58 0.0786
30 APPLICATION SITE IRRITATION 925 0.0743
31 APPLICATION SITE DISCHARGE 85 0.0737
32 MAMMOGRAM ABNORMAL 49 0.0731
33 APPLICATION SITE PRURITUS 1651 0.0727
34 APPLICATION SITE INFLAMMATION 98 0.0708
35 VULVOVAGINAL PRURITUS 350 0.0690
36 SINUSITIS FUNGAL 53 0.0661
37 CYSTOCELE 55 0.0633
38 APPLICATION SITE ERYTHEMA 1640 0.0625
39 VULVOVAGINAL MYCOTIC INFECTION 245 0.0622
40 BREAST TENDERNESS 465 0.0617
41 PRODUCT PACKAGING ISSUE 586 0.0616
42 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 143 0.0602
43 HORMONE LEVEL ABNORMAL 277 0.0567
44 BLADDER PROLAPSE 69 0.0564
45 VAGINAL DISORDER 53 0.0552
46 VULVOVAGINAL SWELLING 98 0.0536
47 PNEUMONIA VIRAL 169 0.0530
48 VAGINAL INFECTION 241 0.0512
49 APPLICATION SITE EROSION 64 0.0497
50 APPLICATION SITE DISCOMFORT 89 0.0495
51 BREAST DISCOMFORT 49 0.0475
52 HOT FLUSH 3474 0.0460
53 APPLICATION SITE VESICLES 290 0.0447
54 NIPPLE PAIN 91 0.0447
55 APPLICATION SITE BURN 214 0.0434
56 VAGINAL DISCHARGE 412 0.0407
57 APPLICATION SITE SWELLING 197 0.0395
58 APPLICATION SITE REACTION 275 0.0391
59 APPLICATION SITE DISCOLOURATION 154 0.0379
60 BACTERIAL VAGINOSIS 59 0.0377
61 FEMALE GENITAL TRACT FISTULA 64 0.0374
62 BREAST CYST 66 0.0372
63 BREAST SWELLING 97 0.0360
64 BLOOD PRESSURE SYSTOLIC ABNORMAL 88 0.0356
65 MENOPAUSE 89 0.0345
66 BREAST ENLARGEMENT 111 0.0339
67 COLITIS MICROSCOPIC 160 0.0337
68 ENDOMETRIAL CANCER 74 0.0336
69 UTERINE POLYP 60 0.0334
70 APPLICATION SITE PAIN 735 0.0333
71 OVARIAN HYPERSTIMULATION SYNDROME 76 0.0326
72 MASTECTOMY 55 0.0314
73 HYSTERECTOMY 267 0.0308
74 BREAST PAIN 326 0.0305
75 THERAPEUTIC PRODUCT INEFFECTIVE 116 0.0300
76 APPLICATION SITE SCAB 63 0.0291
77 PRODUCT SIZE ISSUE 156 0.0290
78 APPLICATION SITE HAEMORRHAGE 79 0.0289
79 CHRONIC SINUSITIS 106 0.0282
80 BREAST DISORDER 57 0.0279
81 INFUSION SITE BRUISING 60 0.0278
82 INTERMENSTRUAL BLEEDING 154 0.0275
83 NIGHT SWEATS 869 0.0269
84 SPUTUM INCREASED 58 0.0268
85 SUSPECTED PRODUCT QUALITY ISSUE 49 0.0267
86 PRE-EXISTING CONDITION IMPROVED 166 0.0266
87 INVASIVE DUCTAL BREAST CARCINOMA 72 0.0265
88 PRODUCT PACKAGING DIFFICULT TO OPEN 69 0.0264
89 DYSPAREUNIA 121 0.0263
90 DEVICE MATERIAL ISSUE 55 0.0261
91 DERMATITIS CONTACT 290 0.0254
92 MACULOPATHY 89 0.0251
93 PRODUCT RESIDUE PRESENT 130 0.0241
94 UTERINE DISORDER 55 0.0236
95 DIASTOLIC DYSFUNCTION 71 0.0230
96 EMBOLISM VENOUS 69 0.0227
97 SYMPTOM RECURRENCE 136 0.0227
98 APPLICATION SITE DRYNESS 77 0.0227
99 PRODUCT SUBSTITUTION ISSUE 1273 0.0221
100 BREAST MASS 147 0.0219
101 REBOUND ACID HYPERSECRETION 66 0.0218
102 PRODUCT PHYSICAL ISSUE 436 0.0216
103 VAGINAL HAEMORRHAGE 937 0.0216
104 FIBROMYALGIA 520 0.0214
105 RESPIRATORY SYMPTOM 60 0.0211
106 DRUG EFFECT INCREASED 66 0.0209
107 UTERINE HAEMORRHAGE 88 0.0206
108 HYPERPARATHYROIDISM SECONDARY 51 0.0203
109 BREAST CANCER METASTATIC 217 0.0202
110 BREAST CANCER 1881 0.0202
111 APPLICATION SITE EXFOLIATION 83 0.0201
112 ENDOMETRIOSIS 94 0.0197
113 MIGRAINE WITH AURA 53 0.0195
114 PRODUCT QUALITY ISSUE 2609 0.0192
115 INFUSION SITE PRURITUS 60 0.0190
116 INTERVERTEBRAL DISC DEGENERATION 175 0.0189
117 PRODUCT ADMINISTRATION INTERRUPTED 147 0.0187
118 INFUSION SITE HAEMORRHAGE 61 0.0185
119 MENINGIOMA 288 0.0184
120 SPINAL STENOSIS 76 0.0184
121 NEPHROGENIC ANAEMIA 85 0.0183
122 BLADDER PAIN 58 0.0183
123 SPINAL OSTEOARTHRITIS 160 0.0182
124 UTERINE LEIOMYOMA 133 0.0182
125 PRODUCT USE COMPLAINT 286 0.0181
126 SYNOVITIS 327 0.0181
127 FUNGAL INFECTION 601 0.0180
128 DIVERTICULUM 128 0.0180
129 RETINAL VEIN OCCLUSION 51 0.0177
130 PRODUCT SOLUBILITY ABNORMAL 87 0.0172
131 OVARIAN CANCER 158 0.0171
132 OSTEOPENIA 258 0.0170
133 DRUG PRESCRIBING ERROR 326 0.0170
134 MENISCUS INJURY 103 0.0167
135 DEVICE PHYSICAL PROPERTY ISSUE 123 0.0160
136 INFUSION SITE SWELLING 100 0.0159
137 TENDERNESS 165 0.0158
138 MIGRAINE 1460 0.0153
139 SKIN REACTION 214 0.0152
140 HAIR GROWTH ABNORMAL 105 0.0152
141 HEPATIC NECROSIS 57 0.0151
142 TRICUSPID VALVE INCOMPETENCE 119 0.0150
143 THYROID DISORDER 229 0.0148
144 SLEEP APNOEA SYNDROME 283 0.0148
145 NASAL POLYPS 73 0.0148
146 PRODUCT AVAILABILITY ISSUE 333 0.0146
147 RHINITIS ALLERGIC 65 0.0146
148 SEASONAL ALLERGY 205 0.0145
149 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 262 0.0143
150 SCOLIOSIS 88 0.0142
151 VITAMIN D DEFICIENCY 137 0.0140
152 COLITIS ISCHAEMIC 94 0.0139
153 BRAIN FOG 217 0.0138
154 HIATUS HERNIA 177 0.0137
155 POOR QUALITY SLEEP 294 0.0136
156 INFUSION SITE ERYTHEMA 115 0.0136
157 PRODUCT PHYSICAL CONSISTENCY ISSUE 75 0.0135
158 METRORRHAGIA 231 0.0135
159 MULTIPLE ALLERGIES 106 0.0135
160 CARPAL TUNNEL SYNDROME 188 0.0134
161 BONE DENSITY ABNORMAL 50 0.0134
162 WRONG TECHNIQUE IN DRUG USAGE PROCESS 483 0.0133
163 DEVICE USE ISSUE 232 0.0132
164 NO ADVERSE EVENT 2377 0.0131
165 DEVICE DEFECTIVE 227 0.0131
166 BURSITIS 158 0.0130
167 POOR QUALITY PRODUCT ADMINISTERED 136 0.0129
168 BLOOD PRESSURE DIASTOLIC DECREASED 95 0.0129
169 CYSTITIS 409 0.0128
170 SPINAL FUSION SURGERY 52 0.0128
171 OSTEOARTHRITIS 540 0.0127
172 MOOD SWINGS 406 0.0127
173 MICTURITION URGENCY 145 0.0127
174 DRUG LEVEL INCREASED 210 0.0127
175 LIGAMENT RUPTURE 56 0.0127
176 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 424 0.0125
177 SPINAL COLUMN STENOSIS 59 0.0125
178 GOITRE 51 0.0124
179 DIVERTICULITIS 342 0.0123
180 VITAMIN D DECREASED 105 0.0123
181 PRODUCT FORMULATION ISSUE 81 0.0123
182 ROSACEA 57 0.0122
183 SYNOVIAL CYST 56 0.0121
184 SINUSITIS 1239 0.0121
185 IRRITABLE BOWEL SYNDROME 259 0.0121
186 EXOSTOSIS 110 0.0120
187 ROTATOR CUFF SYNDROME 153 0.0119
188 OVARIAN CYST 119 0.0119
189 IMPAIRED GASTRIC EMPTYING 160 0.0117
190 OSTEOPOROSIS 482 0.0117
191 INTERVERTEBRAL DISC DISORDER 50 0.0117
192 SKIN ABRASION 55 0.0116
193 CANDIDA INFECTION 196 0.0116
194 EMPHYSEMA 117 0.0116
195 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2345 0.0116
196 BLOOD CHOLESTEROL INCREASED 539 0.0116
197 GLUCOSE TOLERANCE IMPAIRED 68 0.0115
198 ASTHENOPIA 63 0.0115
199 COELIAC DISEASE 112 0.0114
200 BLADDER DISORDER 112 0.0113
201 CONCUSSION 87 0.0112
202 ORAL HERPES 219 0.0112
203 RESTLESS LEGS SYNDROME 204 0.0112
204 MIDDLE INSOMNIA 209 0.0112
205 DRY EYE 555 0.0111
206 PRODUCT COLOUR ISSUE 57 0.0111
207 INFUSION SITE PAIN 143 0.0111
208 BRONCHITIS 821 0.0111
209 ORAL PAIN 247 0.0110
210 BLOOD PRESSURE SYSTOLIC INCREASED 214 0.0110
211 BODY HEIGHT DECREASED 117 0.0109
212 UPPER-AIRWAY COUGH SYNDROME 90 0.0109
213 C-REACTIVE PROTEIN ABNORMAL 70 0.0109
214 FOOT OPERATION 54 0.0109
215 PHARMACEUTICAL PRODUCT COMPLAINT 282 0.0108
216 SKIN LACERATION 118 0.0108
217 CRYING 393 0.0108
218 HYPERLIPIDAEMIA 129 0.0108
219 BLOOD THYROID STIMULATING HORMONE DECREASED 49 0.0108
220 POST-TRAUMATIC STRESS DISORDER 72 0.0107
221 LOW DENSITY LIPOPROTEIN INCREASED 83 0.0107
222 GLAUCOMA 206 0.0107
223 TENDONITIS 164 0.0106
224 STRESS FRACTURE 57 0.0106
225 EYE PAIN 595 0.0105
226 HYPERKERATOSIS 58 0.0105
227 PRODUCT ODOUR ABNORMAL 110 0.0105
228 THERMAL BURN 74 0.0104
229 IRON DEFICIENCY ANAEMIA 96 0.0104
230 ARTHRITIS 818 0.0104
231 ABDOMINAL DISTENSION 1075 0.0103
232 FOOT FRACTURE 195 0.0103
233 AUTOIMMUNE DISORDER 100 0.0102
234 PRODUCT ADMINISTRATION ERROR 207 0.0102
235 DEVICE MALFUNCTION 716 0.0102
236 URINARY INCONTINENCE 300 0.0101
237 LIGAMENT SPRAIN 100 0.0101
238 SCIATICA 161 0.0101
239 NERVE COMPRESSION 92 0.0100
240 FEELING DRUNK 74 0.0099
241 MUSCLE STRAIN 86 0.0099
242 GASTROOESOPHAGEAL REFLUX DISEASE 800 0.0099
243 SCAR 170 0.0099
244 SOMNAMBULISM 65 0.0099
245 CARDIAC FLUTTER 64 0.0099
246 VISUAL FIELD DEFECT 71 0.0098
247 EAR PAIN 189 0.0097
248 SPINAL DISORDER 92 0.0097
249 MOOD ALTERED 264 0.0097
250 LIVER FUNCTION TEST ABNORMAL 281 0.0097
251 FRUSTRATION TOLERANCE DECREASED 78 0.0096
252 INSOMNIA 2567 0.0096
253 DRUG ADMINISTERED AT INAPPROPRIATE SITE 101 0.0096
254 PELVIC PAIN 174 0.0096
255 PALPITATIONS 1121 0.0096
256 POOR VENOUS ACCESS 99 0.0096
257 HERPES ZOSTER 548 0.0095
258 TINNITUS 437 0.0095
259 URINARY TRACT INFECTION 1620 0.0095
260 NECK PAIN 530 0.0095
261 INTERVERTEBRAL DISC PROTRUSION 206 0.0094
262 TEMPERATURE INTOLERANCE 97 0.0094
263 FEELING JITTERY 179 0.0094
264 POOR QUALITY DEVICE USED 94 0.0094
265 THERAPEUTIC RESPONSE UNEXPECTED 419 0.0093
266 RASH PAPULAR 209 0.0093
267 BURNING SENSATION 652 0.0093
268 FACIAL PAIN 83 0.0093
269 PRODUCT LABEL ISSUE 63 0.0093
270 FEELING HOT 569 0.0093
271 TOOTHACHE 168 0.0093
272 NASAL DRYNESS 58 0.0092
273 TOOTH INFECTION 122 0.0092
274 SINUS DISORDER 183 0.0092
275 INCREASED TENDENCY TO BRUISE 85 0.0092
276 DECREASED INTEREST 54 0.0091
277 NEUROLOGICAL SYMPTOM 52 0.0091
278 UPPER RESPIRATORY TRACT INFECTION 420 0.0091
279 PARAESTHESIA ORAL 131 0.0091
280 NEURALGIA 220 0.0090
281 BODY TEMPERATURE DECREASED 89 0.0090
282 AFFECTIVE DISORDER 71 0.0090
283 INCORRECT DRUG ADMINISTRATION DURATION 254 0.0090
284 POLYP 59 0.0090
285 SPINAL OPERATION 111 0.0090
286 HYPERAESTHESIA 74 0.0090
287 FEELING ABNORMAL 2155 0.0090
288 MUSCULOSKELETAL DISCOMFORT 154 0.0089
289 PRODUCT PRESCRIBING ERROR 213 0.0089
290 SKIN WARM 52 0.0089
291 FORMICATION 62 0.0089
292 BRUXISM 48 0.0089
293 DISCOMFORT 542 0.0089
294 HAEMORRHOIDS 173 0.0089
295 SKIN ATROPHY 51 0.0089
296 IRRITABILITY 531 0.0088
297 INSURANCE ISSUE 135 0.0088
298 HYPERHIDROSIS 1136 0.0088
299 NERVE INJURY 98 0.0088
300 FOREIGN BODY SENSATION IN EYES 56 0.0088
301 SINUS HEADACHE 52 0.0087
302 HAIR TEXTURE ABNORMAL 117 0.0087
303 LIMB DISCOMFORT 270 0.0087
304 SLEEP DISORDER 614 0.0087
305 DRY THROAT 88 0.0086
306 HAIR DISORDER 71 0.0086
307 INCONTINENCE 91 0.0086
308 JOINT DISLOCATION 91 0.0086
309 MUSCLE SPASMS 1575 0.0086
310 ANKLE FRACTURE 132 0.0085
311 WRIST FRACTURE 102 0.0085
312 HERPES VIRUS INFECTION 49 0.0085
313 TOXIC EPIDERMAL NECROLYSIS 129 0.0085
314 FEELING COLD 236 0.0085
315 METASTASES TO LYMPH NODES 57 0.0084
316 TOOTH FRACTURE 93 0.0084
317 DEPRESSED MOOD 445 0.0084
318 PHOTOSENSITIVITY REACTION 139 0.0084
319 PSYCHIATRIC SYMPTOM 62 0.0084
320 INCORRECT DOSE ADMINISTERED BY DEVICE 219 0.0083
321 PHOTOPHOBIA 157 0.0083
322 MAJOR DEPRESSION 61 0.0083
323 ALOPECIA 1639 0.0083
324 WEIGHT FLUCTUATION 87 0.0083
325 HEADACHE 5211 0.0083
326 CHRONIC KIDNEY DISEASE 631 0.0083
327 DEPRESSION 1888 0.0083
328 EAR DISCOMFORT 85 0.0083
329 IMPAIRED QUALITY OF LIFE 119 0.0083
330 EYE IRRITATION 476 0.0083
331 ANAL INCONTINENCE 74 0.0082
332 SINUS CONGESTION 111 0.0082
333 BLOOD POTASSIUM DECREASED 247 0.0082
334 SKIN IRRITATION 376 0.0082
335 OCULAR DISCOMFORT 92 0.0082
336 WEIGHT INCREASED 1833 0.0082
337 CYST 100 0.0080
338 VITREOUS FLOATERS 79 0.0080
339 POOR QUALITY DRUG ADMINISTERED 52 0.0080
340 NERVOUSNESS 419 0.0080
341 BONE DISORDER 146 0.0080
342 KIDNEY INFECTION 157 0.0080
343 PRODUCT SUPPLY ISSUE 57 0.0080
344 ANXIETY 2271 0.0080
345 PAIN IN JAW 226 0.0080
346 EYE INFECTION 90 0.0080
347 MUSCLE TIGHTNESS 129 0.0080
348 THERAPEUTIC PRODUCT EFFECT DECREASED 355 0.0079
349 DRY MOUTH 643 0.0079
350 RESPIRATORY DEPRESSION 97 0.0079
351 DISEASE RECURRENCE 376 0.0079
352 PANIC ATTACK 288 0.0079
353 HEAVY MENSTRUAL BLEEDING 71 0.0079
354 MENSTRUAL DISORDER 65 0.0078
355 POSTOPERATIVE WOUND INFECTION 53 0.0078
356 ONYCHOCLASIS 54 0.0078
357 CONTUSION 752 0.0078
358 LYMPHOEDEMA 54 0.0078
359 LIP SWELLING 260 0.0078
360 AFFECT LABILITY 75 0.0078
361 ABDOMINAL PAIN LOWER 197 0.0078
362 GINGIVAL PAIN 62 0.0078
363 FOOT DEFORMITY 86 0.0078
364 SQUAMOUS CELL CARCINOMA 73 0.0077
365 BLOOD CALCIUM INCREASED 68 0.0077
366 EMOTIONAL DISORDER 239 0.0077
367 DRUG EFFECT DECREASED 417 0.0077
368 SENSORY DISTURBANCE 124 0.0077
369 POLLAKIURIA 322 0.0077
370 PAROSMIA 58 0.0077
371 GASTROENTERITIS 112 0.0077
372 FOOD ALLERGY 59 0.0076
373 GASTROINTESTINAL PAIN 84 0.0076
374 HAND FRACTURE 54 0.0076
375 CONTRAINDICATED PRODUCT ADMINISTERED 230 0.0076
376 DYSGRAPHIA 50 0.0076
377 PELVIC FRACTURE 59 0.0076
378 THERAPEUTIC RESPONSE CHANGED 48 0.0076
379 FLANK PAIN 71 0.0076
380 PERIPHERAL COLDNESS 104 0.0076
381 NASAL DISCOMFORT 60 0.0076
382 PRODUCT USE ISSUE 1422 0.0076
383 LIMB INJURY 205 0.0075
384 RENAL PAIN 80 0.0075
385 BLOOD PRESSURE ABNORMAL 150 0.0075
386 INITIAL INSOMNIA 77 0.0075
387 BLOOD PRESSURE FLUCTUATION 180 0.0075
388 DRUG EFFECT LESS THAN EXPECTED 111 0.0075
389 THERAPY CESSATION 383 0.0075
390 HEAD DISCOMFORT 132 0.0074
391 GASTRITIS 196 0.0074
392 RHINITIS 60 0.0074
393 HEART RATE IRREGULAR 168 0.0074
394 VERTIGO 452 0.0074
395 THINKING ABNORMAL 138 0.0074
396 BACK PAIN 1720 0.0074
397 SMALL INTESTINAL OBSTRUCTION 91 0.0074
398 ECONOMIC PROBLEM 112 0.0074
399 HERPES SIMPLEX 48 0.0074
400 MUSCULOSKELETAL CHEST PAIN 114 0.0074
401 TENDON DISORDER 48 0.0074
402 PHARYNGEAL SWELLING 72 0.0074
403 OROPHARYNGEAL PAIN 681 0.0073
404 CHOLECYSTECTOMY 84 0.0073
405 PHARYNGEAL OEDEMA 113 0.0073
406 TRANSIENT ISCHAEMIC ATTACK 247 0.0073
407 VENTRICULAR EXTRASYSTOLES 76 0.0073
408 EYE DISCHARGE 76 0.0073
409 BACK INJURY 79 0.0073
410 ARTHRALGIA 3019 0.0073
411 DYSPEPSIA 713 0.0072
412 PARAESTHESIA 1140 0.0072
413 LACERATION 68 0.0072
414 BALANCE DISORDER 624 0.0072
415 IMPAIRED DRIVING ABILITY 82 0.0072
416 ORAL DISCOMFORT 100 0.0072
417 BLOOD PRESSURE INCREASED 1099 0.0072
418 BLISTER 403 0.0072
419 BACK DISORDER 116 0.0071
420 RESPIRATORY TRACT CONGESTION 113 0.0071
421 DYSMENORRHOEA 94 0.0071
422 NAIL DISORDER 62 0.0071
423 JOINT SWELLING 855 0.0071
424 KNEE ARTHROPLASTY 149 0.0071
425 MADAROSIS 82 0.0071
426 DYSURIA 259 0.0070
427 HEART RATE INCREASED 697 0.0070
428 POST PROCEDURAL COMPLICATION 135 0.0070
429 IMPAIRED WORK ABILITY 150 0.0070
430 DEVICE ISSUE 627 0.0070
431 CHOLELITHIASIS 229 0.0070
432 MITRAL VALVE INCOMPETENCE 79 0.0070
433 BONE PAIN 408 0.0070
434 DISTURBANCE IN ATTENTION 375 0.0069
435 PSYCHOLOGICAL TRAUMA 60 0.0069
436 HYPERSENSITIVITY 1285 0.0069
437 RASH PRURITIC 374 0.0069
438 C-REACTIVE PROTEIN INCREASED 251 0.0069
439 SURGERY 404 0.0069
440 NEPHROLITHIASIS 316 0.0069
441 TENDON RUPTURE 85 0.0069
442 EAR INFECTION 183 0.0069
443 HEPATIC ENCEPHALOPATHY 64 0.0069
444 DIPLOPIA 178 0.0068
445 PRURITUS GENERALISED 148 0.0068
446 PERIPHERAL SWELLING 1054 0.0068
447 PAIN IN EXTREMITY 2015 0.0068
448 LYMPHADENOPATHY 242 0.0068
449 INFLUENZA LIKE ILLNESS 562 0.0068
450 CHEST DISCOMFORT 699 0.0068
451 SWOLLEN TONGUE 213 0.0068
452 PRURITUS 2619 0.0068
453 HEART RATE DECREASED 239 0.0068
454 MUSCULOSKELETAL PAIN 356 0.0068
455 EYE SWELLING 252 0.0068
456 ORAL CANDIDIASIS 89 0.0068
457 RESPIRATORY RATE INCREASED 60 0.0068
458 PRODUCT PRESCRIBING ISSUE 147 0.0067
459 END STAGE RENAL DISEASE 123 0.0067
460 FLUID RETENTION 343 0.0067
461 HYPERCHOLESTEROLAEMIA 65 0.0067
462 GROIN PAIN 59 0.0067
463 AMNESIA 437 0.0067
464 URTICARIA 1125 0.0067
465 ABNORMAL FAECES 55 0.0067
466 HYPERTHYROIDISM 97 0.0067
467 BLOOD TRIGLYCERIDES INCREASED 118 0.0067
468 TOOTH ABSCESS 68 0.0067
469 ELECTROCARDIOGRAM QT PROLONGED 240 0.0067
470 DYSPHONIA 390 0.0067
471 BASAL CELL CARCINOMA 104 0.0067
472 SWELLING FACE 434 0.0067
473 SPINAL COMPRESSION FRACTURE 55 0.0066
474 ILLNESS 685 0.0066
475 EXPIRED PRODUCT ADMINISTERED 221 0.0066
476 FLATULENCE 377 0.0066
477 HYPOTHYROIDISM 211 0.0066
478 VISION BLURRED 906 0.0066
479 COORDINATION ABNORMAL 92 0.0066
480 INTENTIONAL DOSE OMISSION 188 0.0066
481 NOCTURIA 80 0.0066
482 UPPER LIMB FRACTURE 131 0.0066
483 MEMORY IMPAIRMENT 903 0.0066
484 RASH ERYTHEMATOUS 314 0.0066
485 QUALITY OF LIFE DECREASED 88 0.0066
486 RENAL CYST 52 0.0065
487 FLUSHING 664 0.0065
488 VIRAL INFECTION 217 0.0065
489 DIZZINESS POSTURAL 63 0.0065
490 EYELID PTOSIS 66 0.0065
491 SUICIDAL IDEATION 592 0.0065
492 SWELLING 605 0.0065
493 JOINT INJURY 138 0.0065
494 HYPOAESTHESIA 966 0.0064
495 APHONIA 90 0.0064
496 ASTHMA 728 0.0064
497 ABDOMINAL DISCOMFORT 1080 0.0064
498 LACRIMATION INCREASED 194 0.0064
499 DENTAL CARIES 71 0.0064
500 SKIN INFECTION 72 0.0064
501 ANGER 217 0.0064
502 KNEE OPERATION 63 0.0064
503 MUSCLE INJURY 53 0.0064
504 SKIN DISORDER 213 0.0064
505 RHEUMATOID ARTHRITIS 725 0.0064
506 NASAL CONGESTION 375 0.0064
507 IMPAIRED HEALING 209 0.0064
508 COLD SWEAT 112 0.0063
509 MYALGIA 1078 0.0063
510 DRUG INTOLERANCE 612 0.0063
511 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 56 0.0063
512 HEPATIC CIRRHOSIS 119 0.0063
513 RHINORRHOEA 409 0.0063
514 BLOOD IRON DECREASED 75 0.0063
515 HEAD INJURY 200 0.0063
516 SCAB 72 0.0063
517 PROCEDURAL PAIN 175 0.0063
518 NAUSEA 4980 0.0063
519 SENSATION OF FOREIGN BODY 53 0.0063
520 MENTAL IMPAIRMENT 152 0.0063
521 DYSPNOEA EXERTIONAL 236 0.0063
522 TOOTH DISORDER 139 0.0062
523 CHROMATURIA 141 0.0062
524 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 299 0.0062
525 DIZZINESS 3098 0.0062
526 FATIGUE 4832 0.0062
527 MACULAR DEGENERATION 74 0.0062
528 BLOOD THYROID STIMULATING HORMONE INCREASED 57 0.0062
529 ABDOMINAL PAIN UPPER 1270 0.0062
530 DRUG INEFFECTIVE 8129 0.0062
531 SCRATCH 65 0.0062
532 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 338 0.0062
533 ABNORMAL DREAMS 170 0.0062
534 THROAT TIGHTNESS 166 0.0061
535 RASH 2673 0.0061
536 OBSTRUCTIVE AIRWAYS DISORDER 68 0.0061
537 PULMONARY MASS 91 0.0061
538 SKIN SWELLING 53 0.0061
539 UTERINE CANCER 49 0.0061
540 ABDOMINAL PAIN 1419 0.0061
541 GASTROENTERITIS VIRAL 110 0.0061
542 PSORIATIC ARTHROPATHY 247 0.0061
543 ROAD TRAFFIC ACCIDENT 254 0.0061
544 NIGHTMARE 210 0.0061
545 CATARACT 360 0.0060
546 JOINT RANGE OF MOTION DECREASED 81 0.0060
547 PRODUCT DOSE OMISSION ISSUE 1775 0.0060
548 HEPATIC ENZYME INCREASED 411 0.0060
549 MUSCULAR WEAKNESS 685 0.0060
550 ARTHROPATHY 335 0.0060
551 HAIR COLOUR CHANGES 75 0.0060
552 BLOOD MAGNESIUM DECREASED 52 0.0060
553 ACTIVITIES OF DAILY LIVING IMPAIRED 119 0.0060
554 PHARYNGITIS STREPTOCOCCAL 65 0.0060
555 ECZEMA 314 0.0060
556 THERAPY CHANGE 59 0.0060
557 HYPERSOMNIA 172 0.0060
558 THROAT IRRITATION 269 0.0060
559 DRUG LEVEL DECREASED 61 0.0060
560 INTENTIONAL PRODUCT USE ISSUE 525 0.0060
561 SECRETION DISCHARGE 75 0.0060
562 LOWER LIMB FRACTURE 115 0.0060
563 CHEST PAIN 1108 0.0060
564 PAIN 3673 0.0060
565 RASH MACULAR 209 0.0060
566 CONSTIPATION 1301 0.0060
567 COVID-19 1045 0.0060
568 RESPIRATORY TRACT INFECTION 155 0.0059
569 BACTERIAL INFECTION 111 0.0059
570 WEIGHT DECREASED 1659 0.0059
571 MUSCLE DISORDER 48 0.0059
572 PRODUCT DOSE OMISSION 386 0.0059
573 GASTROINTESTINAL INFECTION 53 0.0059
574 GRIP STRENGTH DECREASED 52 0.0059
575 NASOPHARYNGITIS 1088 0.0059
576 GALLBLADDER DISORDER 105 0.0059
577 THIRST 105 0.0059
578 DERMATITIS 123 0.0059
579 SKIN DISCOLOURATION 269 0.0058
580 MUSCLE ATROPHY 74 0.0058
581 HYPOAESTHESIA ORAL 88 0.0058
582 RIB FRACTURE 120 0.0058
583 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 414 0.0058
584 HUNGER 81 0.0058
585 GAIT INABILITY 194 0.0058
586 PHARYNGITIS 72 0.0058
587 MASS 81 0.0058
588 BLOOD URINE PRESENT 110 0.0058
589 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 412 0.0058
590 LOCALISED INFECTION 140 0.0058
591 EATING DISORDER 123 0.0058
592 TREMOR 957 0.0058
593 GAIT DISTURBANCE 1103 0.0058
594 PRESYNCOPE 140 0.0058
595 ERUCTATION 111 0.0057
596 LOCAL SWELLING 100 0.0057
597 SYSTEMIC LUPUS ERYTHEMATOSUS 203 0.0057
598 BIPOLAR DISORDER 62 0.0057
599 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 266 0.0057
600 MUSCLE TWITCHING 131 0.0057
601 HIP ARTHROPLASTY 87 0.0057
602 FEEDING DISORDER 115 0.0057
603 MANIA 93 0.0056
604 LETHARGY 325 0.0056
605 OEDEMA PERIPHERAL 687 0.0056
606 MALNUTRITION 63 0.0056
607 DYSGEUSIA 418 0.0056
608 EYE HAEMORRHAGE 75 0.0056
609 PRESCRIBED UNDERDOSE 112 0.0056
610 INFLUENZA 626 0.0056
611 MOVEMENT DISORDER 180 0.0056
612 CHILLS 657 0.0056
613 APHASIA 169 0.0056
614 PULMONARY THROMBOSIS 61 0.0056
615 UNDERDOSE 408 0.0056
616 SLUGGISHNESS 57 0.0056
617 PRODUCT DOSE OMISSION IN ERROR 158 0.0056
618 DRUG-INDUCED LIVER INJURY 175 0.0056
619 BLOOD SODIUM DECREASED 105 0.0056
620 DISABILITY 110 0.0056
621 CARDIAC MURMUR 48 0.0055
622 COGNITIVE DISORDER 259 0.0055
623 GASTRIC DISORDER 190 0.0055
624 MUSCLE SPASTICITY 68 0.0055
625 OEDEMA 300 0.0055
626 MALAISE 2426 0.0055
627 HYPERTENSION 1171 0.0055
628 JOINT STIFFNESS 145 0.0055
629 WITHDRAWAL SYNDROME 232 0.0055
630 PRODUCT DISPENSING ERROR 120 0.0055
631 CLOSTRIDIUM DIFFICILE INFECTION 120 0.0055
632 SPUTUM DISCOLOURED 52 0.0055
633 OFF LABEL USE 4799 0.0055
634 PRESCRIBED OVERDOSE 106 0.0055
635 HEPATIC STEATOSIS 102 0.0055
636 COUGH 1535 0.0055
637 INJECTION SITE URTICARIA 134 0.0055
638 GLOSSODYNIA 122 0.0054
639 HAEMATOCRIT DECREASED 108 0.0054
640 SNEEZING 122 0.0054
641 INFLAMMATION 280 0.0054
642 MUSCULOSKELETAL STIFFNESS 475 0.0054
643 OCULAR HYPERAEMIA 254 0.0053
644 BODY TEMPERATURE INCREASED 109 0.0053
645 PRODUCTIVE COUGH 255 0.0053
646 TASTE DISORDER 108 0.0053
647 INCORRECT PRODUCT ADMINISTRATION DURATION 115 0.0053
648 FAECES DISCOLOURED 115 0.0053
649 HYPOKINESIA 77 0.0053
650 NEUROPATHY PERIPHERAL 504 0.0053
651 CHOLECYSTITIS 63 0.0053
652 INFECTION 764 0.0053
653 DRUG INTERACTION 836 0.0053
654 GASTROINTESTINAL DISORDER 471 0.0053
655 ANOSMIA 76 0.0052
656 INCORRECT DOSE ADMINISTERED 1197 0.0052
657 SUPRAVENTRICULAR TACHYCARDIA 50 0.0052
658 NODULE 68 0.0052
659 RENAL TUBULAR NECROSIS 51 0.0052
660 DISORIENTATION 206 0.0052
661 SKIN HAEMORRHAGE 77 0.0052
662 DEEP VEIN THROMBOSIS 337 0.0052
663 ATELECTASIS 50 0.0052
664 MOUTH ULCERATION 109 0.0052
665 SPEECH DISORDER 271 0.0052
666 FALL 1718 0.0052
667 WHITE BLOOD CELL COUNT INCREASED 198 0.0052
668 ANKYLOSING SPONDYLITIS 68 0.0052
669 LEUKOPENIA 258 0.0052
670 STAPHYLOCOCCAL INFECTION 170 0.0051
671 DRUG ADMINISTRATION ERROR 158 0.0051
672 FREQUENT BOWEL MOVEMENTS 139 0.0051
673 WHEEZING 305 0.0051
674 APATHY 75 0.0051
675 CELLULITIS 259 0.0051
676 PRODUCT USE IN UNAPPROVED INDICATION 1273 0.0051
677 DIARRHOEA HAEMORRHAGIC 48 0.0051
678 FEMUR FRACTURE 159 0.0051
679 INCREASED APPETITE 98 0.0051
680 CHOKING 100 0.0051
681 BLOOD TEST ABNORMAL 72 0.0051
682 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 923 0.0051
683 CONDITION AGGRAVATED 1557 0.0051
684 INJECTION SITE RASH 157 0.0051
685 DRUG EFFECT INCOMPLETE 185 0.0051
686 PULMONARY EMBOLISM 483 0.0051
687 DEVICE DIFFICULT TO USE 336 0.0051
688 DIARRHOEA 3268 0.0051
689 SKIN CANCER 109 0.0051
690 PLATELET COUNT INCREASED 66 0.0051
691 INJECTION SITE PRURITUS 339 0.0051
692 IMMUNODEFICIENCY 75 0.0050
693 ERYTHEMA 1033 0.0050
694 HEMIPARESIS 85 0.0050
695 UNEVALUABLE EVENT 379 0.0050
696 DECREASED ACTIVITY 54 0.0050
697 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 85 0.0050
698 DYSSTASIA 146 0.0050
699 PRODUCT COMPLAINT 126 0.0050
700 RETCHING 106 0.0050
701 AGEUSIA 124 0.0050
702 ULCER 79 0.0050
703 HELICOBACTER INFECTION 51 0.0050
704 VISUAL IMPAIRMENT 614 0.0049
705 SPINAL PAIN 58 0.0049
706 PRODUCT TASTE ABNORMAL 67 0.0049
707 INABILITY TO AFFORD MEDICATION 49 0.0049
708 DRUG DOSE OMISSION 814 0.0049
709 INJECTION SITE WARMTH 101 0.0049
710 GINGIVAL BLEEDING 67 0.0049
711 OBESITY 78 0.0049
712 PETECHIAE 51 0.0049
713 ASTHENIA 1837 0.0049
714 ABORTION SPONTANEOUS 195 0.0049
715 DERMATITIS ALLERGIC 61 0.0048
716 RASH GENERALISED 125 0.0048
717 EYE PRURITUS 162 0.0048
718 MULTIPLE SCLEROSIS 230 0.0048
719 GLOMERULAR FILTRATION RATE DECREASED 59 0.0048
720 BLOOD ALKALINE PHOSPHATASE INCREASED 119 0.0048
721 STOMATITIS 290 0.0048
722 MUSCULOSKELETAL DISORDER 91 0.0048
723 IMMUNE SYSTEM DISORDER 63 0.0048
724 EYE DISORDER 157 0.0048
725 FOLLICULITIS 50 0.0048
726 OESOPHAGITIS 52 0.0048
727 PARANOIA 82 0.0048
728 PAIN OF SKIN 128 0.0047
729 INTESTINAL OBSTRUCTION 179 0.0047
730 DEVICE DELIVERY SYSTEM ISSUE 130 0.0047
731 INJECTION SITE BRUISING 378 0.0047
732 INFUSION RELATED REACTION 314 0.0047
733 COLITIS 179 0.0047
734 SINUS TACHYCARDIA 67 0.0047
735 HYPOACUSIS 203 0.0047
736 INJECTION SITE ERYTHEMA 579 0.0047
737 WOUND INFECTION 51 0.0047
738 VOMITING 2185 0.0046
739 FEAR 125 0.0046
740 RESTLESSNESS 170 0.0046
741 ADVERSE REACTION 61 0.0046
742 SOMNOLENCE 923 0.0046
743 OSTEOMYELITIS 83 0.0046
744 RED BLOOD CELL COUNT DECREASED 131 0.0046
745 GASTRIC ULCER 87 0.0046
746 INTENTIONAL PRODUCT MISUSE 400 0.0046
747 DYSPNOEA 2581 0.0046
748 PANCREATITIS ACUTE 102 0.0045
749 DEVICE BREAKAGE 184 0.0045
750 RENAL INJURY 134 0.0045
751 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 77 0.0045
752 LOWER RESPIRATORY TRACT INFECTION 204 0.0045
753 MALIGNANT MELANOMA 60 0.0045
754 DYSARTHRIA 168 0.0045
755 ADVERSE DRUG REACTION 400 0.0044
756 SKIN LESION 122 0.0044
757 DYSKINESIA 180 0.0044
758 CONJUNCTIVITIS 82 0.0044
759 SKIN FISSURES 86 0.0044
760 DERMATITIS ATOPIC 232 0.0044
761 DEHYDRATION 585 0.0044
762 RECTAL HAEMORRHAGE 188 0.0044
763 HYPERCALCAEMIA 54 0.0044
764 THERAPEUTIC RESPONSE SHORTENED 145 0.0044
765 WOUND 122 0.0044
766 DYSPHAGIA 414 0.0044
767 TUBULOINTERSTITIAL NEPHRITIS 81 0.0043
768 DEAFNESS 113 0.0043
769 LYMPHOCYTE COUNT DECREASED 76 0.0043
770 SKIN ULCER 111 0.0043
771 ANGINA PECTORIS 123 0.0043
772 HIP FRACTURE 138 0.0043
773 MOBILITY DECREASED 307 0.0043
774 BLOOD CALCIUM DECREASED 48 0.0043
775 DRY SKIN 568 0.0043
776 AGITATION 312 0.0042
777 SPINAL FRACTURE 85 0.0042
778 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 221 0.0042
779 RESPIRATORY DISORDER 126 0.0042
780 MENTAL DISORDER 183 0.0042
781 ADRENAL INSUFFICIENCY 51 0.0042
782 INCORRECT PRODUCT STORAGE 55 0.0042
783 MULTIPLE SCLEROSIS RELAPSE 282 0.0041
784 URINARY RETENTION 137 0.0041
785 HAEMORRHAGE 428 0.0041
786 THERAPY NON-RESPONDER 184 0.0041
787 HEPATOTOXICITY 91 0.0041
788 OXYGEN SATURATION DECREASED 229 0.0041
789 PANCREATITIS 215 0.0041
790 ABASIA 100 0.0040
791 DEPRESSED LEVEL OF CONSCIOUSNESS 160 0.0040
792 PSORIASIS 528 0.0040
793 PSYCHOMOTOR HYPERACTIVITY 67 0.0040
794 MENORRHAGIA 79 0.0040
795 CONFUSIONAL STATE 649 0.0040
796 SKIN BURNING SENSATION 287 0.0040
797 LIVER FUNCTION TEST INCREASED 86 0.0040
798 TREATMENT NONCOMPLIANCE 219 0.0040
799 ILL-DEFINED DISORDER 243 0.0040
800 SKIN EXFOLIATION 335 0.0040
801 ATRIAL FIBRILLATION 386 0.0040
802 INJURY 278 0.0040
803 SYNCOPE 394 0.0039
804 TOOTH EXTRACTION 49 0.0039
805 INJECTION SITE PAIN 1207 0.0039
806 THROMBOSIS 316 0.0039
807 ISCHAEMIC STROKE 70 0.0039
808 THERAPY INTERRUPTED 280 0.0039
809 LOSS OF CONSCIOUSNESS 501 0.0039
810 CARDIOMEGALY 48 0.0039
811 HERNIA 75 0.0039
812 HALLUCINATION 291 0.0039
813 DRUG DISPENSING ERROR 59 0.0039
814 ANAPHYLACTIC REACTION 213 0.0039
815 INJECTION SITE REACTION 265 0.0038
816 MULTIPLE FRACTURES 63 0.0038
817 EXPOSURE VIA SKIN CONTACT 99 0.0038
818 INJECTION SITE SWELLING 292 0.0038
819 SEROTONIN SYNDROME 73 0.0038
820 DECREASED APPETITE 881 0.0038
821 SARS-COV-2 TEST POSITIVE 50 0.0038
822 PARALYSIS 54 0.0038
823 TYPE 2 DIABETES MELLITUS 127 0.0038
824 PNEUMONIA 1220 0.0038
825 BONE DENSITY DECREASED 118 0.0038
826 MEDICATION ERROR 209 0.0038
827 RENAL FAILURE 497 0.0037
828 MYDRIASIS 48 0.0037
829 DIABETES MELLITUS 285 0.0037
830 BEDRIDDEN 49 0.0037
831 ANOREXIA 48 0.0037
832 EPISTAXIS 278 0.0037
833 INJECTION SITE INDURATION 48 0.0037
834 TREATMENT FAILURE 306 0.0037
835 ACNE 280 0.0037
836 BLINDNESS UNILATERAL 52 0.0037
837 ACUTE KIDNEY INJURY 564 0.0037
838 NEEDLE ISSUE 107 0.0037
839 TACHYCARDIA 324 0.0036
840 GLYCOSYLATED HAEMOGLOBIN INCREASED 92 0.0036
841 CENTRAL NERVOUS SYSTEM LESION 50 0.0036
842 HYPOPHAGIA 93 0.0036
843 PERICARDITIS 61 0.0036
844 INJECTION SITE MASS 134 0.0036
845 PSYCHOTIC DISORDER 107 0.0036
846 ORTHOSTATIC HYPOTENSION 63 0.0036
847 ADVERSE EVENT 333 0.0036
848 ARRHYTHMIA 171 0.0036
849 ANAEMIA 682 0.0036
850 ABSCESS 57 0.0036
851 CORONARY ARTERY DISEASE 108 0.0036
852 PYREXIA 1217 0.0035
853 BLINDNESS 143 0.0035
854 BLOOD PRESSURE DECREASED 232 0.0035
855 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 102 0.0035
856 HALLUCINATION, AUDITORY 55 0.0035
857 THERAPEUTIC RESPONSE DECREASED 209 0.0034
858 HAEMATOCHEZIA 189 0.0034
859 HYPOKALAEMIA 158 0.0034
860 PULMONARY HYPERTENSION 71 0.0034
861 HEPATOCELLULAR INJURY 48 0.0034
862 INJECTION SITE HAEMATOMA 49 0.0034
863 NERVOUS SYSTEM DISORDER 105 0.0034
864 HAEMOGLOBIN DECREASED 344 0.0033
865 ANHEDONIA 88 0.0033
866 CEREBROVASCULAR ACCIDENT 562 0.0033
867 OSTEONECROSIS OF JAW 82 0.0033
868 GENERALISED TONIC-CLONIC SEIZURE 54 0.0033
869 DEMENTIA 91 0.0033
870 LEUKOCYTOSIS 58 0.0032
871 MENTAL STATUS CHANGES 89 0.0032
872 VISUAL ACUITY REDUCED 106 0.0032
873 MATERNAL EXPOSURE DURING PREGNANCY 284 0.0032
874 LABORATORY TEST ABNORMAL 94 0.0032
875 DEVICE RELATED INFECTION 49 0.0032
876 ASPARTATE AMINOTRANSFERASE INCREASED 169 0.0032
877 COLITIS ULCERATIVE 142 0.0032
878 BLOOD UREA INCREASED 53 0.0032
879 DRUG ERUPTION 56 0.0032
880 LUNG INFECTION 49 0.0032
881 HYPOTENSION 632 0.0031
882 PULMONARY FIBROSIS 60 0.0031
883 CARDIAC DISORDER 291 0.0031
884 HYPONATRAEMIA 175 0.0031
885 ABNORMAL BEHAVIOUR 123 0.0031
886 CARDIAC FAILURE CONGESTIVE 248 0.0031
887 TOOTH LOSS 64 0.0031
888 HEPATITIS 78 0.0030
889 ALANINE AMINOTRANSFERASE INCREASED 185 0.0030
890 HAEMATOMA 78 0.0030
891 RENAL DISORDER 140 0.0030
892 COAGULOPATHY 50 0.0030
893 INJURY ASSOCIATED WITH DEVICE 61 0.0030
894 HALLUCINATION, VISUAL 63 0.0030
895 CONVULSION 170 0.0030
896 BLOOD POTASSIUM INCREASED 48 0.0030
897 WHITE BLOOD CELL COUNT DECREASED 319 0.0029
898 LUNG DISORDER 143 0.0029
899 INTENTIONAL DRUG MISUSE 61 0.0029
900 ACUTE RESPIRATORY FAILURE 56 0.0029
901 FRACTURE 55 0.0029
902 SEDATION 75 0.0029
903 EPILEPSY 87 0.0028
904 LIVER DISORDER 125 0.0028
905 HYPOCALCAEMIA 53 0.0028
906 INJECTION SITE HAEMORRHAGE 223 0.0028
907 GOUT 50 0.0028
908 ANGIOEDEMA 122 0.0028
909 EMOTIONAL DISTRESS 331 0.0027
910 PRODUCT STORAGE ERROR 239 0.0027
911 LIVER INJURY 67 0.0027
912 PRODUCT PREPARATION ERROR 56 0.0027
913 SEIZURE 314 0.0027
914 HAEMATURIA 91 0.0027
915 HAEMOPTYSIS 71 0.0025
916 GENERAL PHYSICAL HEALTH DETERIORATION 291 0.0025
917 BLOOD BILIRUBIN INCREASED 67 0.0025
918 RENAL IMPAIRMENT 207 0.0025
919 AGGRESSION 123 0.0025
920 PLEURAL EFFUSION 149 0.0024
921 PULMONARY OEDEMA 109 0.0024
922 NEOPLASM MALIGNANT 161 0.0024
923 PALLOR 65 0.0024
924 PERICARDIAL EFFUSION 55 0.0024
925 SUICIDE ATTEMPT 143 0.0024
926 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
927 DEVICE LEAKAGE 101 0.0023
928 ACCIDENTAL EXPOSURE TO PRODUCT 240 0.0023
929 HYPOXIA 82 0.0023
930 ASCITES 68 0.0023
931 HAEMATEMESIS 58 0.0023
932 DRUG WITHDRAWAL SYNDROME 200 0.0023
933 EXTRA DOSE ADMINISTERED 92 0.0023
934 MYOCARDIAL INFARCTION 389 0.0022
935 BLOOD CREATINE PHOSPHOKINASE INCREASED 64 0.0022
936 BLOOD CREATININE INCREASED 145 0.0022
937 TRANSAMINASES INCREASED 49 0.0022
938 TARDIVE DYSKINESIA 62 0.0022
939 ACCIDENTAL OVERDOSE 80 0.0022
940 RENAL FAILURE ACUTE 92 0.0022
941 HYPOGLYCAEMIA 102 0.0021
942 ACUTE MYOCARDIAL INFARCTION 62 0.0021
943 PLATELET COUNT DECREASED 219 0.0021
944 BLOOD GLUCOSE INCREASED 387 0.0021
945 SEPSIS 228 0.0020
946 DIABETIC KETOACIDOSIS 49 0.0020
947 ENCEPHALOPATHY 50 0.0020
948 PNEUMONITIS 55 0.0020
949 BRADYCARDIA 107 0.0020
950 EXPOSURE DURING PREGNANCY 125 0.0020
951 RHABDOMYOLYSIS 83 0.0020
952 MENSTRUATION IRREGULAR 53 0.0020
953 ANAPHYLACTIC SHOCK 51 0.0020
954 HYPERGLYCAEMIA 72 0.0020
955 BLOOD GLUCOSE DECREASED 93 0.0019
956 PREMATURE BABY 58 0.0019
957 HEPATIC FAILURE 56 0.0019
958 GASTROINTESTINAL HAEMORRHAGE 154 0.0018
959 OSTEONECROSIS 60 0.0018
960 NEUTROPHIL COUNT DECREASED 73 0.0018
961 HOSPITALISATION 269 0.0017
962 PLASMA CELL MYELOMA 68 0.0017
963 DEVICE DISLOCATION 73 0.0017
964 DEVICE USE ERROR 57 0.0016
965 INTERSTITIAL LUNG DISEASE 79 0.0016
966 DELIRIUM 56 0.0016
967 INCORRECT ROUTE OF DRUG ADMINISTRATION 56 0.0016
968 OVERDOSE 335 0.0016
969 CEREBRAL HAEMORRHAGE 55 0.0015
970 DRUG DOSE OMISSION BY DEVICE 118 0.0015
971 RESPIRATORY FAILURE 109 0.0015
972 LUNG NEOPLASM MALIGNANT 59 0.0014
973 TOXICITY TO VARIOUS AGENTS 232 0.0014
974 DISEASE PROGRESSION 162 0.0014
975 PANCYTOPENIA 76 0.0014
976 SEPTIC SHOCK 57 0.0013
977 THROMBOCYTOPENIA 144 0.0013
978 COMA 58 0.0012
979 COMPLETED SUICIDE 101 0.0012
980 FOETAL EXPOSURE DURING PREGNANCY 98 0.0012
981 NEUTROPENIA 161 0.0012
982 FEBRILE NEUTROPENIA 74 0.0011
983 CARDIAC FAILURE 86 0.0011
984 CARDIAC ARREST 87 0.0011
985 INTENTIONAL OVERDOSE 67 0.0010
986 MALIGNANT NEOPLASM PROGRESSION 80 0.0008
987 DRUG DEPENDENCE 115 0.0007
988 DEATH 574 0.0007
989 DRUG ABUSE 54 0.0006